Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAPVAY Long-Term Efficacy in Pediatric ADHD
NCT01439126Phase 4Completed
- Sponsor
- Concordia Pharmaceuticals Inc.
- Start
- Aug 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clonidine in attention deficit hyperactivity disorder (ADHD), sponsored by Concordia Pharmaceuticals Inc.. Started Aug 2011; status: completed.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01439126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439126.